Geneva, Switzerland – June 27, 2024 – STALICLA SA, a Swiss neuro precision biotech company dedicated to developing precision medicine-based treatments for neuropsychiatric and neurodevelopmental ...
GENEVA--(BUSINESS WIRE)--STALICLA SA, today announced first patient enrolled in its Phase 1b clinical trial with STP1, a first in class precision medicine for patients within the autism spectrum ...
Find the live Stepup USD (STP1-USD) price, history, news and other vital information to help with your cryptocurrency trading and investing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback